PRAX vs. ICPT, TVTX, SAGE, CMPS, MGNX, BHVN, ACLX, TGTX, IDYA, and IOVA
Should you be buying Praxis Precision Medicines stock or one of its competitors? The main competitors of Praxis Precision Medicines include Intercept Pharmaceuticals (ICPT), Travere Therapeutics (TVTX), Sage Therapeutics (SAGE), COMPASS Pathways (CMPS), MacroGenics (MGNX), Biohaven (BHVN), Arcellx (ACLX), TG Therapeutics (TGTX), IDEAYA Biosciences (IDYA), and Iovance Biotherapeutics (IOVA). These companies are all part of the "medical" sector.
Intercept Pharmaceuticals (NASDAQ:ICPT) and Praxis Precision Medicines (NASDAQ:PRAX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and community ranking.
83.8% of Intercept Pharmaceuticals shares are owned by institutional investors. Comparatively, 67.8% of Praxis Precision Medicines shares are owned by institutional investors. 6.2% of Intercept Pharmaceuticals shares are owned by insiders. Comparatively, 2.7% of Praxis Precision Medicines shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Intercept Pharmaceuticals received 1029 more outperform votes than Praxis Precision Medicines when rated by MarketBeat users. Likewise, 71.69% of users gave Intercept Pharmaceuticals an outperform vote while only 69.81% of users gave Praxis Precision Medicines an outperform vote.
Intercept Pharmaceuticals has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, Praxis Precision Medicines has a beta of 2.72, suggesting that its share price is 172% more volatile than the S&P 500.
Intercept Pharmaceuticals has higher revenue and earnings than Praxis Precision Medicines. Intercept Pharmaceuticals is trading at a lower price-to-earnings ratio than Praxis Precision Medicines, indicating that it is currently the more affordable of the two stocks.
In the previous week, Praxis Precision Medicines had 25 more articles in the media than Intercept Pharmaceuticals. MarketBeat recorded 26 mentions for Praxis Precision Medicines and 1 mentions for Intercept Pharmaceuticals. Praxis Precision Medicines' average media sentiment score of 0.51 beat Intercept Pharmaceuticals' score of 0.30 indicating that Praxis Precision Medicines is being referred to more favorably in the news media.
Intercept Pharmaceuticals has a net margin of -19.39% compared to Praxis Precision Medicines' net margin of -6,987.01%. Praxis Precision Medicines' return on equity of -61.47% beat Intercept Pharmaceuticals' return on equity.
Intercept Pharmaceuticals currently has a consensus target price of $19.00, suggesting a potential upside of 0.00%. Praxis Precision Medicines has a consensus target price of $143.44, suggesting a potential upside of 165.54%. Given Praxis Precision Medicines' stronger consensus rating and higher probable upside, analysts plainly believe Praxis Precision Medicines is more favorable than Intercept Pharmaceuticals.
Summary
Intercept Pharmaceuticals and Praxis Precision Medicines tied by winning 9 of the 18 factors compared between the two stocks.
Get Praxis Precision Medicines News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Praxis Precision Medicines Competitors List
Related Companies and Tools
